keyword
https://read.qxmd.com/read/38617837/concomitant-bedaquiline-and-delamanid-therapy-in-patients-with-drug-resistant-extra-pulmonary-tuberculosis-in-mumbai-india
#21
JOURNAL ARTICLE
Himani Mongia, Fatima Mamnoon, Arunima Silsarma, Raman Mahajan, Alpa Dalal, Miriam Arago Galindo, Aparna Iyer, Pramila Singh, Homa Mansoor, Mrinalini Das, Mabel Morales, Hannah Spencer, Petros Isaakidis
BACKGROUND: World Health Organization suggests concurrent bedaquiline-delamanid (BDQ-DLM) as part of individualised regimens for eligible patients with pulmonary drug-resistant tuberculosis (DR-TB); however, data for patients with drug-resistant extrapulmonary tuberculosis (EPTB) is extremely limited. This study documents the treatment outcomes and adverse events associated with concurrent BDQ-DLM-based regimens in patients with drug-resistant EPTB at a Médecins Sans Frontières clinic in Mumbai, India...
May 2024: Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
https://read.qxmd.com/read/38617382/tak-3-inhibits-lipopolysaccharide-induced-neuroinflammation-in-traumatic-brain-injury-rats-through-the-tlr-4-nf-%C3%AE%C2%BAb-pathway
#22
JOURNAL ARTICLE
Pengwei Hou, Yang Yang, Ziqi Li, Dan Ye, Li Chen, Tianshun Feng, Jiateng Zeng, Liangfeng Wei, Shousen Wang
PURPOSE: The activation of the inflammatory response is regarded as a pivotal factor in the pathogenesis of TBI. Central nervous system infection often leads to the exacerbation of neuroinflammation following TBI, primarily caused by Gram-negative bacteria. This study aims to elucidate the effects of the novel anti-inflammatory drug TAK-3 on LPS-induced neuroinflammation in TBI rats. METHODS: In conjunction with the rat controlled cortical impact model, we administered local injections of Lipopolysaccharide to the impact site...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38617282/microglia-and-macrophages-alterations-in-the-cns-during-acute-siv-infection-a-single-cell-analysis-in-rhesus-macaques
#23
Xiaoke Xu, Meng Niu, Benjamin G Lamberty, Katy Emanuel, Andrew J Trease, Mehnaz Tabassum, Jeffrey D Lifson, Howard S Fox
UNLABELLED: Human Immunodeficiency Virus (HIV) is widely acknowledged for its profound impact on the immune system. Although HIV primarily affects peripheral CD4 T cells, its influence on the central nervous system (CNS) cannot be overlooked. Within the brain, microglia and CNS-associated macrophages (CAMs) serve as the primary targets for HIV, as well as for the simian immunodeficiency virus (SIV) in nonhuman primates. This infection can lead to neurological effects and the establishment of a viral reservoir...
April 4, 2024: bioRxiv
https://read.qxmd.com/read/38615394/neuroinvasion-and-neurotropism-of-severe-acute-respiratory-syndrome-coronavirus-2-infection
#24
REVIEW
Michelle Jagst, Lilli Pottkämper, André Gömer, Kalliopi Pitarokoili, Eike Steinmann
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019, contributes to neurological pathologies in nearly 30% of patients, extending beyond respiratory symptoms. These manifestations encompass disorders of both the peripheral and central nervous systems, causing among others cerebrovascular issues and psychiatric manifestations during the acute and/or post-acute infection phases. Despite ongoing research, uncertainties persist about the precise mechanism the virus uses to infiltrate the central nervous system and the involved entry portals...
April 13, 2024: Current Opinion in Microbiology
https://read.qxmd.com/read/38615370/altered-ebv-specific-immune-control-in-multiple-sclerosis
#25
JOURNAL ARTICLE
Christian Münz
Since the 1980s it is known that immune responses to the Epstein-Barr virus (EBV) are elevated in multiple sclerosis (MS) patients. Recent seroepidemiologial data have shown that this alteration after primary EBV infection identifies individuals with a more than 30-fold increased risk to develop MS. The mechanisms by which EBV infection might erode tolerance for the central nervous system (CNS) in these individuals, years prior to clinical MS onset, remain unclear. In this review I will discuss altered frequencies of EBV life cycle stages and their tissue distribution, EBV with CNS autoantigen cross-reactive immune responses and loss of immune control for autoreactive B and T cells as possible mechanisms...
April 5, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38614954/phase-3-immunogenicity-and-safety-study-of-a-tick-borne-encephalitis-vaccine-in-healthy-japanese-participants-1-year-of-age-and-older
#26
JOURNAL ARTICLE
Motoharu Yonekawa, Tohru Watanabe, Osamu Kogawara, Chihiro Yoshii, Masako Yamaji, Masakazu Aizawa, Wilhelm Erber, Shuhei Ito, Bogdan Jug, Doris Koelch, Richard de Solom, Stephen P Lockhart
BACKGROUND: Tick-borne encephalitis (TBE) virus infects the central nervous system and may lead to severe neurological complications or death. This study assessed immunogenicity, safety, and tolerability of TBE vaccine in Japanese participants 1 year of age and older. METHODS: This phase 3, multicenter, single-arm, open-label study was conducted in Japanese adult (≥ 16 years) and pediatric (1-< 16 years) populations. Participants received a single 0...
April 12, 2024: Vaccine
https://read.qxmd.com/read/38614162/external-validation-of-the-si-2-ncal-2-c-score-for-outcomes-following-cerebral-venous-thrombosis
#27
JOURNAL ARTICLE
Piers Klein, Liqi Shu, Erik Lindgren, Maria A de Winter, James E Siegler, Alexis N Simpkins, Satareh Salehi Omran, Mirjam R Heldner, Adam de Havenon, Mohamad Abdalkader, Sami Al Kasab, Christoph Stretz, Teddy Y Wu, Duncan Wilson, Syed Daniyal Asad, Eyad Almallouhi, Jennifer Frontera, Lindsey Kuohn, Aaron Rothstein, Ekaterina Bakradze, Nils Henninger, Adeel S Zubair, Richa Sharma, Deborah Kerrigan, Yasmin Aziz, Eva A Mistry, Mayte Sanchez van Kammen, Turgut Tatlisumak, Katarzyna Krzywicka, Diana Aguiar de Sousa, Katarina Jood, Thalia S Field, Shadi Yaghi, Jonathan M Coutinho, Thanh N Nguyen
OBJECTIVES: Prognostication for cerebral venous thrombosis (CVT) remains difficult. We sought to validate the SI2 NCAL2 C score in an international cohort. MATERIALS AND METHODS: The SI2 NCAL2 C score was originally developed to predict poor outcome (modified Rankin Scale (mRS) 3-6) at 6 months, and mortality at 30 days and 1 year using data from the International CVT Consortium. The SI2 NCAL2 C score uses 9 variables: the absence of any female-sex-specific risk factors, intracerebral hemorrhage, central nervous system infection, focal neurological deficits, coma, age, lower level of hemoglobin, higher level of glucose, and cancer...
April 11, 2024: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://read.qxmd.com/read/38613657/comprehensive-risk-factor-predictions-for-3-year-survival-among-hiv-associated-and-disseminated-cryptococcosis-involving-lungs-and-central-nervous-system
#28
JOURNAL ARTICLE
Luling Wu, Xuemin Fu, Benno Pütz, Renfang Zhang, Li Liu, Wei Song, Ling Weng, Yueming Shao, Zhihang Zheng, Jingna Xun, Ximei Han, Ting Wang, Yinzhong Shen, Hongzhou Lu, Bertram Müller-Myhsok, Jun Chen
BACKGROUND: The global mortality rate resulting from HIV-associated cryptococcal disease is remarkably elevated, particularly in severe cases with dissemination to the lungs and central nervous system (CNS). Regrettably, there is a dearth of predictive analysis regarding long-term survival, and few studies have conducted longitudinal follow-up assessments for comparing anti-HIV and antifungal treatments. METHODS: A cohort of 83 patients with HIV-related disseminated cryptococcosis involving the lung and CNS was studied for 3 years to examine survival...
April 13, 2024: Infection
https://read.qxmd.com/read/38610464/non-invasive-alcohol-concentration-measurement-using-a-spectroscopic-module-outlook-for-the-development-of-a-drunk-driving-prevention-system
#29
JOURNAL ARTICLE
Yechan Cho, Wonjune Lee, Heock Sin, Suseong Oh, Kyo Chang Choi, Jae-Hoon Jun
Alcohol acts as a central nervous system depressant and falls under the category of psychoactive drugs. It has the potential to impair vital bodily functions, including cognitive alertness, muscle coordination, and induce fatigue. Taking the wheel after consuming alcohol can lead to delayed responses in emergency situations and increases the likelihood of collisions with obstacles or suddenly appearing objects. Statistically, drivers under the influence of alcohol are seven times more likely to cause accidents compared to sober individuals...
April 1, 2024: Sensors
https://read.qxmd.com/read/38610091/modulation-of-immune-responses-in-the-central-nervous-system-by-zika-virus-west-nile-virus-and-dengue-virus
#30
REVIEW
Shuhui Wu, Ting Zhang, Weidong Qiang, Yang Yang
Arthropod-borne viruses (arboviruses) pose significant threats to global public health by causing a spectrum of diseases ranging from mild febrile illnesses to severe neurological complications. Understanding the intricate interplay between arboviruses and the immune system within the central nervous system is crucial for developing effective strategies to combat these infections and mitigate their neurological sequelae. This review comprehensively explores the mechanisms by which arboviruses such as Zika virus, West Nile virus, and Dengue virus manipulate immune responses within the CNS, leading to diverse clinical manifestations...
May 2024: Reviews in Medical Virology
https://read.qxmd.com/read/38608516/sars-cov-2-infection-increases-long-term-multiple-sclerosis-disease-activity-and-all-cause-mortality-in-an-underserved-inner-city-population
#31
JOURNAL ARTICLE
Roham Hadidchi, Stephen H Wang, David Rezko, Sonya Henry, Patricia K Coyle, Tim Q Duong
BACKGROUND: Although certain subsets patients with multiple sclerosis (MS), an immune-mediated disorder, are at higher risk of worse acute COVID-19 outcomes compared to the general population, it is not clear whether SARS-CoV-2 infection impacts long-term outcomes compared with MS patients without COVID-19 infection. OBJECTIVES: This study investigated MS disease activity and mortality 3.5 years post SARS-CoV-2 infection and compared with MS patients without COVID-19...
April 8, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38607469/the-association-between-children-s-autism-spectrum-disorders-and-central-nervous-system-infections-using-a-nationwide-claims-database
#32
JOURNAL ARTICLE
Takanori Yanai, Satomi Yoshida, Koji Kawakami
Several studies have reported an association of autism spectrum disorder (ASD) with central nervous system (CNS) infections and intrauterine infections; however, the results remain unclear. This study aimed to examine this issue using an extensive national database. Utilizing JMDC medical claims database, we conducted a retrospective cohort study of children with at least three years of follow-up from birth, ensuring the mother's information was available. The focus was on the relationship between ASD incidence and exposures like viral meningitis/encephalitis, bacterial meningitis, and intrauterine infections...
April 12, 2024: Journal of Autism and Developmental Disorders
https://read.qxmd.com/read/38607271/idiopathic-intracranial-hypertension-as-the-initial-presenting-manifestation-of-systemic-lupus-erythematosus-in-a-child
#33
JOURNAL ARTICLE
Murugan Sudhakar, Anu P Kocheril, Anish S George, George I Vettiyil, Anitha Jasper, Sathish Kumar
Idiopathic intracranial hypertension (IIH) is a diagnosis of exclusion characterized by features of raised intracranial pressure (ICP) in the absence of brain parenchymal lesion, vascular malformations, hydrocephalus, or central nervous system (CNS) infection. Commonly used other terms for this entity include benign intracranial hypertension (BIH) or pseudotumor cerebri. Few case reports of systemic lupus erythematosus (SLE) presenting as IIH are available in the literature. We report a 12-year-old girl presented with chronic holocranial headache and occasional episodes of projectile vomiting for the last 6 months and then developed blurring of vision for the last month...
April 12, 2024: Lupus
https://read.qxmd.com/read/38605812/development-of-adenoviral-vectors-that-transduce-purkinje-cells-and-other-cerebellar-cell-types-in-the-cerebellum-of-a-humanized-mouse-model
#34
JOURNAL ARTICLE
Emre Kul, Uchechi Okoroafor, Amanda Dougherty, Lauren Palkovic, Hao Li, Paula Valiño-Ramos, Leah Aberman, Samuel M Young
Viral vector gene therapy has immense promise for treating central nervous system (CNS) disorders. Although adeno-associated virus vectors (AAVs) have had success, their small packaging capacity limits their utility to treat the root cause of many CNS disorders. Adenoviral vectors (Ad) have tremendous potential for CNS gene therapy approaches. Currently, the most common vectors utilize the Group C Ad5 serotype capsid proteins, which rely on the Coxsackievirus-Adenovirus receptor (CAR) to infect cells. However, these Ad5 vectors are unable to transduce many neuronal cell types that are dysfunctional in many CNS disorders...
June 13, 2024: Molecular Therapy. Methods & Clinical Development
https://read.qxmd.com/read/38605501/-cell-blocking-the-parasitic-imposter-in-a-rare-case-of-isolated-pulmonary-cysticercosis
#35
JOURNAL ARTICLE
Kush Kumar Singh, Abhilasha Kochhar, Chakshu Bansal, Latika Gupta, Samir Malhotra
Isolated pulmonary cysticercosis is a rare manifestation of human cysticercosis which mainly affects central nervous system, skeletal muscles, eyes and subcutaneous tissues. Pulmonary involvement is usually a part of disseminated disease and mainly presents as bilateral pulmonary nodules. We report a rare case of isolated pulmonary cysticercosis presenting as lung cyst with pleural effusion. The diagnosis was made on pleural fluid cytology and cell block preparation. Herein we wish to recapitulate the importance of cell block as a diagnostic aid for parasitic infections, where morphological features and architectural patterns are as clearly discernable as in histopathology...
April 11, 2024: Diagnostic Cytopathology
https://read.qxmd.com/read/38604001/efficacy-and-safety-of-ocrelizumab-in-patients-with-relapsing-multiple-sclerosis-real-world-experience-of-two-swiss-multiple-sclerosis-centers
#36
JOURNAL ARTICLE
L Diem, A Ovchinnikov, C Friedli, H Hammer, N Kamber, A Chan, A Salmen, O Findling, R Hoepner
BACKGROUND: Ocrelizumab (OCR) is a humanized monoclonal antibody directed against CD-20 positive lymphocytes, mainly B-lymphocytes. OCR is approved for treatment of primary progressive (PPMS) and relapsing multiple sclerosis (RMS). This study aims to provide real-world safety and efficacy data of people with RMS treated with OCR in two Swiss Multiple Sclerosis (MS) centers. METHODS: We have conducted a retrospective data analysis using the patient cohorts from the Cantonal Hospital Aarau and Bern University Hospital (RMS: n = 235)...
March 30, 2024: Multiple Sclerosis and related Disorders
https://read.qxmd.com/read/38602260/ebv-infection-drives-ms-pathology-yes
#37
JOURNAL ARTICLE
Francesca Aloisi, Marco Salvetti
No abstract text is available yet for this article.
April 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38602259/ebv-infection-drives-ms-pathology-commentary
#38
JOURNAL ARTICLE
Marianna Cortese, Alberto Ascherio
No abstract text is available yet for this article.
April 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38602258/ebv-infection-drives-ms-pathology-no
#39
JOURNAL ARTICLE
Bert A 't Hart, Marvin M van Luijn
No abstract text is available yet for this article.
April 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38602163/solid-organ-transplant-related-central-nervous-system-infections
#40
JOURNAL ARTICLE
Oscar Morado-Aramburo, Rodrigo Hasbun
PURPOSE OF REVIEW: Central nervous system (CNS) infections in solid organ transplant (SOT) recipients may present atypical or nonspecific symptoms. Due to a wider range of infectious agents compared with immunocompetent hosts, diagnosis is challenging. This review categorizes CNS infections in SOT recipients by cause. RECENT FINDINGS: New studies have reported new data on the epidemiology and the risk factors associated with each specific pathogen described in this review...
April 2, 2024: Current Opinion in Infectious Diseases
keyword
keyword
40718
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.